Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease.

[1]  R. Fresa,et al.  Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene. , 2009, Molecular genetics and metabolism.

[2]  C. Agostoni,et al.  Combined hyperlipidaemia as a presenting sign of cholesteryl ester storage disease , 2009, Journal of Inherited Metabolic Disease.

[3]  H. Du,et al.  42. Wolman disease/cholesteryl ester storage disease: Efficacy of plant-produced human lysosomal acid lipase in mice , 2009 .

[4]  O. Mühlemann,et al.  Recognition and elimination of nonsense mRNA. , 2008, Biochimica et biophysica acta.

[5]  D. Ameis,et al.  Characterization of lysosomal acid lipase mutations in the signal peptide and mature polypeptide region causing Wolman disease. , 2001, Journal of lipid research.

[6]  G. Bryson,et al.  Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease. , 1999, Molecular genetics and metabolism.

[7]  D. Häussinger,et al.  Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase -1 exon 8 splice junction mutation. , 1999, Journal of hepatology.

[8]  P. Meikle,et al.  Prevalence of lysosomal storage disorders. , 1999, JAMA.

[9]  F. Baralle,et al.  New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease. , 1998, Journal of lipid research.

[10]  H. Du,et al.  Molecular and enzymatic analyses of lysosomal acid lipase in cholesteryl ester storage disease. , 1998, Molecular genetics and metabolism.

[11]  R. Salvayre,et al.  Cholesteryl ester storage disease: relationship between molecular defects and in situ activity of lysosomal acid lipase. , 1997, Biochemical and molecular medicine.

[12]  P. Lohse,et al.  Human lysosomal acid lipase/cholesteryl ester hydrolase and human gastric lipase: identification of the catalytically active serine, aspartic acid, and histidine residues. , 1997, Journal of lipid research.

[13]  G. Schmitz,et al.  Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity. , 1996, Genomics.

[14]  H. Du,et al.  Characterization of Lysosomal Acid Lipase by Site-directed Mutagenesis and Heterologous Expression (*) , 1995, The Journal of Biological Chemistry.

[15]  G. Brockmann,et al.  A 5' splice-region mutation and a dinucleotide deletion in the lysosomal acid lipase gene in two patients with cholesteryl ester storage disease. , 1995, Journal of lipid research.

[16]  L. Zagato,et al.  A histidine to tyrosine replacement in lysosomal acid lipase causes cholesteryl ester storage disease. , 1994, Human molecular genetics.

[17]  K. Lackner,et al.  Genomic organization of the human lysosomal acid lipase gene (LIPA). , 1994, Genomics.

[18]  C. Eckerskorn,et al.  Purification, characterization and molecular cloning of human hepatic lysosomal acid lipase. , 1994, European journal of biochemistry.

[19]  R. Anderson,et al.  Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. Similarities to gastric and lingual lipases. , 1991, The Journal of biological chemistry.

[20]  J. Hoeg,et al.  Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency. , 1984, American journal of human genetics.

[21]  A. Beaudet,et al.  Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease. , 1975, The Journal of biological chemistry.

[22]  J. Tolar,et al.  Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease , 2009, Bone Marrow Transplantation.

[23]  B. Attar,et al.  Cholesterol Ester Storage Disease (CESD) Diagnosed in an Asymptomatic Adult , 2008, Digestive Diseases and Sciences.

[24]  G. Besley,et al.  Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease. , 2000, Journal of lipid research.

[25]  A. Tanaka.  [Acid lipase deficiency (Wolman disease and cholesteryl ester storage disease: CESD)]. , 1998, Ryoikibetsu shokogun shirizu.

[26]  D. Bowden,et al.  In situ localization of the genetic locus encoding the lysosomal acid lipase/cholesteryl esterase (LIPA) deficient in Wolman disease to chromosome 10q23.2-q23.3. , 1993, Genomics.

[27]  G. N. Sando,et al.  Recognition and receptor-mediated endocytosis of the lysosomal acid lipase secreted by cultured human fibroblasts. , 1982, Journal of lipid research.

[28]  B. Burton,et al.  Acid lipase cross-reacting material in Wolman disease and cholesterol ester storage disease. , 1981, American journal of human genetics.